Fundraising Fox
/Companies
Sign in

Peca Labs

Pittsburgh, US · Founded 2012 · Delaware corporation

Find your way into Peca Labs

Sign up to see every warm intro you have to Peca Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Peca Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform. Its devices target both pediatric and adult patients, with the MASA Valve currently under investigational use in a U.S. clinical trial.

BiotechHealthtechMedical DevicesNew Materials

Founders & leadership

Peca Labs was founded in 2012 by C. Douglas Bernstein, Doug Bernstein, Dr. Arush Kalra, and Jamie Quinterno.

CD
C. Douglas BernsteinCEO
DBDoug Bernstein
Doug BernsteinCEO, Co-Founder
DADr. Arush Kalra
Dr. Arush KalraCSO, Co-Founder
JQ
Jamie QuinternoCOO, Co-Founder
DS
David SmithExecutive

Board

SNSamuel Navarro
Samuel NavarroBoard director
MM
Michael MoriartyBoard director
DJDr. Jeffrey Carpenter
Dr. Jeffrey CarpenterBoard director
JO
Jeff O?DonnellBoard director
JK
Jon KuhnBoard director
DJ
Dr. Joseph BavariaBoard director
BH
Brandon HaynesBoard director

Reported raises · per SEC filings

Form D private placements

$21.4M disclosed across 9 rounds · 2015–2025

▶$2.7MraisedNov 2025 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon HaynesDirector
  • Dr. Joseph BavariaDirector
  • Barbara CarryerDirector
  • Jon KuhnDirector
  • Dr. Jeffrey CarpenterDirector
  • Michael MoriartyDirector
  • Samuel NavarroDirector
  • C. Douglas BernsteinExecutive Officer, Director
  • Jeff O?DonnellDirector
Offering amount
$5M
Amount sold
$2.7M
First sale
Nov 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.9MraisedDec 2024 · 32 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael MoriartyDirector
  • Dr. Jeffrey CarpenterDirector
  • Samuel NavarroDirector
  • Jeff O?DonnellDirector
  • Jon KuhnDirector
  • C. Douglas BernsteinExecutive Officer, Director
  • Dr. Joseph BavariaDirector
  • Brandon HaynesDirector
  • Barbara CarryerDirector
Offering amount
$16.5M
Amount sold
$13.9M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$618.2KraisedNov 2022 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara CarryerDirector
  • Michael MoriartyDirector
  • David SmithExecutive Officer
  • James BrowneDirector
  • Douglas BernsteinExecutive Officer, Director
  • Jon KuhnDirector
Amount sold
$618.2K
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$99.2KraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DicksonDirector
  • Michael MoriartyDirector
  • Jon KuhnDirector
  • Babs CarryerDirector
  • Douglas BernsteinExecutive Officer, Director
  • David SmithExecutive Officer
  • James BrowneDirector
Offering amount
$1.8M
Amount sold
$99.2K
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$587.5KraisedJun 2020 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James BrowneDirector
  • Robert DicksonDirector
  • Jon KuhnDirector
  • Michael MoriartyDirector
  • David SmithExecutive Officer
  • Douglas BernsteinExecutive Officer, Director
  • Babs CarryerDirector
Offering amount
$2.1M
Amount sold
$587.5K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$93.8KraisedFeb 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert DicksonDirector
  • Michael MoriartyDirector
  • James BrowneDirector
  • Douglas BernsteinExecutive Officer, Director
  • David SmithExecutive Officer
  • Jon KuhnDirector
  • Babs CarryerDirector
Offering amount
$1.6M
Amount sold
$93.8K
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Babs CarryerDirector
  • David SmithExecutive Officer
  • James BrowneDirector
  • Robert DicksonDirector
  • Michael MoriartyDirector
  • Douglas BernsteinExecutive Officer, Director
Offering amount
$1.4M
Amount sold
$1.4M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedNov 2016 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David SmithExecutive Officer
  • Michael MoriartyDirector
  • Robert DicksonDirector
  • Douglas BernsteinExecutive Officer, Director
  • Babs CarryerDirector
  • James BrowneDirector
Offering amount
$750K
Amount sold
$750K
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.

Companies working in the same space as Peca Labs.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$998K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$149.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Peca Labs do?
PECA Labs develops cardiovascular implants—including vascular grafts and the MASA Valve, a polymeric bi-leaflet valved conduit for pulmonary valve reconstruction—based on a proprietary tunable polymeric material platform. Its devices target both pediatric and adult patients, with the MASA Valve currently under investigational use in a U.S. clinical trial.
Who founded Peca Labs?
Peca Labs was founded by C. Douglas Bernstein, Doug Bernstein, Dr. Arush Kalra, Jamie Quinterno in 2012.
How much funding has Peca Labs raised?
Peca Labs has disclosed $21.4M raised across 9 rounds.
Where is Peca Labs headquartered?
Peca Labs is headquartered in Pittsburgh, US.